Cited by 114Schizophrenia research and treatmentElectroconvulsive Therapy StudiesNeurotransmitter Receptor Influence on Behavior

The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.

Tardive dyskinesia: are first signs reversible?

F M Quitkin, Arthur E. Rifkin, L Gochfeld, Donald F. Klein·1977·American Journal of Psychiatry

DOI 10.1176/ajp.134.1.84

Open this paper in CoChat — free account

Abstract

Although tardive dyskinesia, a serious and sometimes irreversible side effect of antipsychotic drug use, is becoming increasingly common, there is still considerable confusion concerning the course of the syndrome. The authors observed 12 psychiatric patients with tardive dyskinesia from the inception of the syndrome. They found that first symptoms rarely persisted if antipsychotics were discontinued and concluded that the length of time symptoms have persisted prior to drug discontinuation, not age at onset, may be the major variable determining reversibility of the syndrome.

Integrity signals

Registry

Crossref · 10.1176/ajp.134.1.84

Cites

16 of 16 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Treatment of Tardive Dyskinesia
Kazamatsuri, H. (1972) · Archives of General Psychiatry · doi:10.1001/archpsyc.1972.01750250081011 · Cited by 140
A Study of Facial Dyskinesia in a Mental Hospital Population
Brandon, S., McClelland, H. A., & Protheroe, C. (1971) · The British Journal of Psychiatry · doi:10.1192/bjp.118.543.171 · Cited by 138
Treatment of Tardive Dyskinesia
Kazamatsuri, H. (1972) · Archives of General Psychiatry · doi:10.1001/archpsyc.1972.01750250086012 · Cited by 109
Extrapyramidal Disorders After Prolonged Phenothiazine Therapy
Kennedy, P. F., Hershon, H. I., & McGuire, R. (1971) · The British Journal of Psychiatry · doi:10.1192/bjp.118.546.509 · Cited by 98
Choline for Tardive Dyskinesia
Davis, K. L., Berger, P. A., & Hollister, L. E. (1975) · New England Journal of Medicine · doi:10.1056/nejm197507172930317 · Cited by 89
HL-A Antigens and Antibody Response after Influenza a Vaccination
Spencer, M. J., Cherry, J. D., & Terasaki, P. I. (1976) · New England Journal of Medicine · doi:10.1056/nejm197601012940104 · Cited by 85
Neurological Syndromes Associated With Antipsychotic Drug Use
Freedman, D. X. (1973) · Archives of General Psychiatry · doi:10.1001/archpsyc.1973.01750340009001 · Cited by 84
Observations on the effect of levodopa on tardive lingual-facial-buccal dyskinesia
Klawans, H. L., & McKendall, R. R. (1971) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(71)90087-6 · Cited by 71
Tardive Dyskinesia and Drug Therapy in Geriatric Patients
Crane, G. E. (1974) · Archives of General Psychiatry · doi:10.1001/archpsyc.1974.01760090055009 · Cited by 59
Neurotransmitters
Axelrod, J. (1974) · Scientific American · doi:10.1038/scientificamerican0674-58 · Cited by 59

Flagged first, then by citations

Show all 16 references

Research works printed but not linked: 2

Klawans, 1973, The Pharmacology of Extrapyramidal Movement Disorders. Monographs in Neural Sciences, vol 2. 5 Karger
Cole JO, 1975, Dcc

Sorted by citations

Changes in Prevalence, Severity, and Recovery in Tardive Dyskinesia With Age
Smith, J. M. (1980) · Archives of General Psychiatry · doi:10.1001/archpsyc.1980.01780250054006 · Cited by 310
Dopaminergic supersensitivity after neuroleptics: time-course and specificity
Muller, P., & Seeman, P. (1978) · Psychopharmacology · doi:10.1007/bf00429171 · Cited by 271
“Early withdrawal after the dyskinetic symptoms are first observed improves the prognosis (Crane, 1973; Quitkin et al., 1977).”
Background
Tardive Dyskinesia—Reversible and Persistent
Jeste, D. V. (1979) · Archives of General Psychiatry · doi:10.1001/archpsyc.1979.01780050095012 · Cited by 198
Neuroleptic drug-induced extrapyramidal syndromes and tardive dyskinesia
Casey, D. E. (1991) · Schizophrenia Research · doi:10.1016/0920-9964(91)90029-q · Cited by 190
Tardive dyskinesia: summary of a Task Force Report of the American Psychiatric Association. By the Task Force on Late Neurological Effects of Antipsychotic Drugs
(1980) · American Journal of Psychiatry · doi:10.1176/ajp.137.10.1163 · Cited by 192
The discontinuance of maintenance neuroleptic therapy in chronic schizophrenic patients: drug and social consequences
Johnson, D. A. W., Pasterski, G., Ludlow, J. M., Street, K., & Taylor, R. D. W. (1983) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1983.tb00351.x · Cited by 160
“gested as causes, or Contributory causes, of T-D (23-34).”
Background
Therapeutic Strategies Against Tardive Dyskinesia
Jeste, D. V. (1982) · Archives of General Psychiatry · doi:10.1001/archpsyc.1982.04290070037008 · Cited by 160
A Method for Tapering Antipsychotic Treatment That May Minimize the Risk of Relapse
Horowitz, M. A., Jauhar, S., Natesan, S., Murray, R. M., & Taylor, D. (2021) · Schizophrenia Bulletin · doi:10.1093/schbul/sbab017 · Cited by 157
Factors related to tardive dyskinesia
Chouinard, G., Annable, L., Ross‐Chouinard, A., & Nestoros, J. N. (1979) · American Journal of Psychiatry · doi:10.1176/ajp.136.1.79 · Cited by 150
Loss of striatal cholinergic neurons as a basis for tardive and L-dopa-induced dyskinesias, neuroleptic-induced supersensitivity psychosis and refractory schizophrenia
Miller, R. J., & Chouinard, G. (1993) · Biological Psychiatry · doi:10.1016/0006-3223(93)90044-e · Cited by 133
Penrsistent Tardive Dyskinesia in Bipolar Patients
Mukherjee, S. (1986) · Archives of General Psychiatry · doi:10.1001/archpsyc.1986.01800040052008 · Cited by 112
Predictors of improvement in tardive dyskinesia following discontinuation of neuroleptic medication
Glazer, W. M., Morgenstern, H., Schooler, N., Berkman, C. S., & Moore, D. C. (1990) · British Journal of Psychiatry · doi:10.1192/bjp.157.4.585 · Cited by 106
Neuroleptic-Induced Acute Extrapyramidal Syndromes and Tardive Dyskinesia
Casey, D. E. (1993) · Psychiatric Clinics of North America · doi:10.1016/s0193-953x(18)30166-7 · Cited by 101
Antipsychotic-induced extrapyramidal symptoms and their management
Dayalu, P., & Chou, K. L. (2008) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.9.9.1451 · Cited by 101
In Search of Treatment for Tardive Dyskinesia: Review of the Literature*
Jeste, D. V., & Wyatt, R. J. (1979) · Schizophrenia Bulletin · doi:10.1093/schbul/5.2.251 · Cited by 93
Neuroleptic Side Effects: Acute Extrapyramidal Syndromes and Tardive Dyskinesia
Casey, D. E., & Keepers, G. A. (1988) · Springer eBooks · doi:10.1007/978-3-642-73280-5_7 · Cited by 75
Adverse Effects of Antipsychotic Agents
Simpson, G. M., Pi, E. H., & Sramek, J. J. (1981) · Drugs · doi:10.2165/00003495-198121020-00004 · Cited by 73
The Medical Care of Patients With Psychiatric Illness
Karasu, T. B., Waltzman, S. A., Lindenmayer, J., & Buckley, P. J. (1980) · Psychiatric Services · doi:10.1176/ps.31.7.463 · Cited by 70
Tardive Syndromes are Rarely Reversible after Discontinuing Dopamine Receptor Blocking Agents: Experience from a University-based Movement Disorder Clinic
Zutshi, D., Factor, S., & Cloud, L. J. (2014) · PubMed Central · doi:10.7916/d85h7dzx · Cited by 67
Tardive Dyskinesia
Glazer, W. M. (1984) · Archives of General Psychiatry · doi:10.1001/archpsyc.1984.01790170097011 · Cited by 64
Overview: public health issues in tardive dyskinesia
Gárdos, G., & Cole, J. O. (1980) · American Journal of Psychiatry · doi:10.1176/ajp.137.7.776 · Cited by 64
Neuroleptic reduction and/or cessation and neuroleptics as specific treatments for tardive dyskinesia
Soares‐Weiser, K., & Rathbone, J. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000459.pub2 · Cited by 60
Tardive dyskinesia and antiparkinsonian medication
Chouinard, G., de Montigny, C., & Annable, L. (1979) · American Journal of Psychiatry · doi:10.1176/ajp.136.2.228 · Cited by 58
Differentiating tardive dyskinesia: a video-based review of antipsychotic-induced movement disorders in clinical practice
Hauser, R. A., Meyer, J. M., Factor, S. A., Comella, C., Tanner, C. M., Xavier, R. M., Caroff, S. N., & Lundt, L. (2020) · CNS Spectrums · doi:10.1017/s109285292000200x · Cited by 57
“DRBA treatment should be reviewed for possible switch or discontinuation (only in patients who are not psychotic and can be safely tapered) especially if TD is detected early; 23,24 unfortunately, early signs of TD are often missed, and it may become irreversible once established.”
Historical perspectives on tardive dyskinesia
Caroff, S. N., Ungvari, G. S., & Cunningham Owens, D. G. (2018) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2018.02.015 · Cited by 55
Long-Acting Oral vs Injectable Antipsychotic Drugs in Schizophrenics
Quitkin, F. M. (1978) · Archives of General Psychiatry · doi:10.1001/archpsyc.1978.01770310095007 · Cited by 55
Tardive Dyskinesia: Reversible and Irreversible
Casey, D. E. (1985) · Psychopharmacology series · doi:10.1007/978-3-642-70140-5_11 · Cited by 54
The effects of electroconvulsive therapy on tardive dyskinesia
Tr, P., & Levin, R. (1978) · American Journal of Psychiatry · doi:10.1176/ajp.135.8.991 · Cited by 53
L-DOPA reversal of hyperdopaminergic behaviour
Ezrin‐Waters, C., & Seeman, P. M. (1978) · Life Sciences · doi:10.1016/0024-3205(78)90271-0 · Cited by 50
Antipsychotic reduction and/or cessation and antipsychotics as specific treatments for tardive dyskinesia
Bergman, H., Rathbone, J., Agarwal, V., & Soares‐Weiser, K. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000459.pub3 · Cited by 50
Tardive Dyskinesia: Barriers to the Professional Recognition of an Iatrogenic Disease
Brown, P., & Funk, S. C. (1986) · Journal of Health and Social Behavior · doi:10.2307/2136311 · Cited by 47
“throughout the course of TD (Quitkin et al. 1977).”
Systematic review of interventions for treating or preventing antipsychotic-induced tardive dyskinesia
Bergman, H., Walker, D., Nikolakopoulou, A., Soares‐Weiser, K., & Adams, C. E. (2017) · Health Technology Assessment · doi:10.3310/hta21430 · Cited by 45
Emerging drugs in Tourette syndrome
Silay, Y. S., & Jankovic, J. J. (2005) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.10.2.365 · Cited by 44
“In a series of 12 psychiatric patients, 24 – 62 years old, tardive dyskinesia developed after treatment for as short a period as 1 month to as long as 10 years [67].”
Background
Can the supersensitivity of rodents to dopamine be regarded as a model of tardive dyskinesia?
Wolfarth, S., & Ossowska, K. (1989) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/0278-5846(89)90036-5 · Cited by 44
Current Methods for the Treatment and Prevention of Drug-Induced Parkinsonism and Tardive Dyskinesia in the Elderly
Estevez‐Fraga, C., Zeun, P., & López-Sendón, J. L. (2018) · Drugs & Aging · doi:10.1007/s40266-018-0590-y · Cited by 36
Overcoming barriers to effective management of tardive dyskinesia
Caroff, S. N. (2019) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s196541 · Cited by 37
“older reports found remission from TD a few months after drug cessation occurring in 50%–75% of patients if detected early.(45,46) While these early cases may represent reversible withdrawal dyskinesias, they nevertheless support the potential efficacy of drug withdrawal in nonpsychotic patients as a management option.”
Background
Management of Tardive Syndrome: Medications and Surgical Treatments
Factor, S. A. (2020) · Neurotherapeutics · doi:10.1007/s13311-020-00898-3 · Cited by 37
Failure of lithium treatment in established tardive dyskinesia
Mackay, A. V. P., Sheppard, G. P., Saha, B. K., Motley, B., Johnson, A. L., & MARSDEN, C. D. (1980) · Psychological Medicine · doi:10.1017/s0033291700047498 · Cited by 33
“The situation could be different in recent-onset TD where a prophylactic action of Li might prevent further deterioration of dyskinesia in those patients requiring continued neuroleptic medication (Quitkin et al. 1977).”
Background
Neuroleptics and the Elderly
Peabody, C. A., Warner, M. D., Whiteford, H., & Hollister, L. E. (1987) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1987.tb02315.x · Cited by 33
Tardive dyskinesia and informed consent
Sovner, R., DiMascio, A., Berkowitz, D., & Randolph, P. (1978) · Psychosomatics · doi:10.1016/s0033-3182(78)71009-1 · Cited by 32
Recent Advances in the Pharmacology of Tardive Dyskinesia
Caroff, S. N. (2020) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.2020.18.4.493 · Cited by 31
“ter drug withdrawal [54-56], older reports found remission of TD after drug cessation occurring in 50−75% of patients if detected early [57,58].”
Background
New strategies for old problems: tardive dyskinesia (TD) Review and report on severe TD cases treated with clozapine, with 12, 8 and 5 years of video follow-up
Larach, V. W., Zamboni, R., Mancini, H. R., Rueda, R. M., & Torres, R. G. (1997) · Schizophrenia Research · doi:10.1016/s0920-9964(97)00130-8 · Cited by 29
Relationship Between the B-Mitten EEG Pattern and Tardive Dyskinesia
Wegner, J. T. (1979) · Archives of General Psychiatry · doi:10.1001/archpsyc.1979.01780050109016 · Cited by 28
Management of Tardive Dyskinesia
Simpson, G. M., Pi, E. H., & Sramek, J. J. (1982) · Drugs · doi:10.2165/00003495-198223050-00003 · Cited by 27
Follow-up study on the reversibility of tardive dyskinesia
Wegner, J. T., & Kane, J. M. (1982) · American Journal of Psychiatry · doi:10.1176/ajp.139.3.368 · Cited by 27
The differential diagnosis of tardive dyskinesia
Casey, D. E. (1981) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1981.tb02460.x · Cited by 25
A 10‐year follow‐up study of tardive dyskinesia
YASSA, R., & Nair, N. P. V. (1992) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1992.tb03264.x · Cited by 24
Tardive Dyskinesia and Problems of Assessment
Barnes, T. R. E., & Kidger, T. (1979) · Palgrave Macmillan UK eBooks · doi:10.1007/978-1-349-04494-8_12 · Cited by 24
Progress in the Treatment of Tardive Dyskinesia: Theory and Practice
Feltner, D. E., & Hertzman, M. (1993) · Psychiatric Services · doi:10.1176/ps.44.1.25 · Cited by 23
Early onset of tardive dyskinesia: case report
(1979) · American Journal of Psychiatry · doi:10.1176/ajp.136.10.1323 · Cited by 20
Treatment of Tardive Dyskinesia
Lhoste, F., Lemaire, F., & RAPIN, M. (1977) · New England Journal of Medicine · doi:10.1056/nejm197704282961718 · Cited by 20
Antipsychotic-Induced Tardive Dyskinesia
Cavallaro, R., & Smeraldi, E. (1995) · CNS Drugs · doi:10.2165/00023210-199504040-00005 · Cited by 18
Psychopharmakotherapie affektiver Psychosen
Woggon, B. (1987) · Springer eBooks · doi:10.1007/978-3-642-71819-9_10 · Cited by 18
Tardive Syndromes
Friedman, J. H. (2019) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/con.0000000000000754 · Cited by 18
A 10-year follow-up study of tardive dyskinesia. With special reference to the influence of neuroleptic administration on the long-term prognosis.
Yagi, G., & Itoh, H. (1985) · The Keio Journal of Medicine · doi:10.2302/kjm.34.211 · Cited by 17
Tardive Dyskinesia: Management and New Treatment
Casey, D. E., & Gerlach, J. (1984) · Springer eBooks · doi:10.1007/978-94-011-7618-7_12 · Cited by 17
A new era in the diagnosis and treatment of tardive dyskinesia
Caroff, S. N. (2022) · CNS Spectrums · doi:10.1017/s1092852922000992 · Cited by 16
Follow-up study of 11 patients with potentially reversible tardive dyskinesia
Yagi, G., & Itoh, H. (1987) · American Journal of Psychiatry · doi:10.1176/ajp.144.11.1496 · Cited by 16
Choline chloride in animal models of tardive dyskinesia
Davis, K. L., Hollister, L. E., Vento, A. L., & Simonton, S. C. (1978) · Life Sciences · doi:10.1016/0024-3205(78)90621-5 · Cited by 16
A single-blind study of ECT in patients with tardive dyskinesia
Asnis, G. M., & Leopold, M. A. (1978) · American Journal of Psychiatry · doi:10.1176/ajp.135.10.1235 · Cited by 15
Tardive dyskinesia: Myths and Realities
Ananth, J. (1980) · Psychosomatics · doi:10.1016/s0033-3182(80)73668-x · Cited by 15
Effects of Neuroleptic Reduction in Schizophrenic Outpatients Receiving High Doses
Leblanc, G., Cormier, H. J., Gagné, M.-A., & Vaillancourt, S. (1994) · The Canadian Journal of Psychiatry · doi:10.1177/070674379403900406 · Cited by 15
“o :activation' (3-21); e : anxiety-depressiori" (4-28) ; .”
Background
Six month evaluation of thiopropazate hydrochloride in tardive dyskinesia.
Smith, J. S., & Kiloh, L. G. (1979) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.42.6.576 · Cited by 14
Tardive Dyskinesia and Other Drug-Induced Movement Disorders
FANN, W. E. (1980) · Springer eBooks · doi:10.1007/978-94-011-6381-1_21 · Cited by 14
Management of the Behavioral Symptoms Associated with Dementia
Eimer, M. (1989) · Primary Care Clinics in Office Practice · doi:10.1016/s0095-4543(21)01099-x · Cited by 13
Clinical controversies in tardive dyskinesia
Mackay, A. V. P. (1981) · Elsevier eBooks · doi:10.1016/b978-0-407-02295-9.50019-9 · Cited by 13
Neuroleptic reduction and/or cessation and neuroleptics as specific treatments for tardive dyskinesia
McGrath, J. J., & Soares-Weiser, K. (1998) · doi:10.1002/14651858.cd000459 · Cited by 13
Long-Term Drug Treatment of Psychosis: Observations on some Current Issues
Johnson, D. A. W. (1990) · International Review of Psychiatry · doi:10.3109/09540269009026605 · Cited by 10
Type I tardive dyskinesia induced by anticholinergic drugs, dopamine agonists and neuroleptics
Chouinard, G., & Steinberg, S. I. (1982) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(82)80151-6 · Cited by 10
Prevention/treatment of tardive dyskinesia
Gerlach, J. (1981) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1981.tb02464.x · Cited by 10
“As TD is reversible in the beginning (Quitkin et al. (1977)) it is crucial to detect the syndrome as early as possible.”
Background
Neuroleptic-opiod interaction: Relevance to tardive dyskinesia
Sandyk, R. (1986) · International Journal of Neuroscience · doi:10.3109/00207458608985652 · Cited by 10
Tardive Syndromes in the Elderly
Chou, K. L., & Friedman, J. H. (2006) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2006.06.008 · Cited by 9
Tardive Dyskinesia in Psychogeriatric Patients: A Five‐Year Follow‐Up
Mehta, D., Mehta, S., & Mathew, P. (1977) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1977.tb00839.x · Cited by 9
Neuroleptic‐Induced Acute Extrapyramidal Syndromes and Tardive Dyskinesia
Mattay, V. S., & Casey, D. E. (2003) · doi:10.1002/9780470987353.ch28 · Cited by 9
Drug-Induced Tardive Dyskinesia
Itoh, H. (1981) · Springer eBooks · doi:10.1007/978-94-011-8123-5_4 · Cited by 8
Neurological Complications of Antipsychotic Drugs
Haddad, P. M., & Mattay, V. S. (2010) · Wiley eBooks · doi:10.1002/9781444327298.ch27 · Cited by 8
Psychoses
Gelenberg, A. J. (1983) · Springer eBooks · doi:10.1007/978-1-4615-8049-2_4 · Cited by 8
The tardive syndromes
Fahn, S., Jankovic, J. J., & Hallett, M. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-2369-4.00019-6 · Cited by 7
Prevention of Tardive Dyskinesia
Pi, E. H., & Simpson, G. M. (1986) · Springer eBooks · doi:10.1007/978-1-4684-5038-5_9 · Cited by 7
Psychoses
Gelenberg, A. J. (1991) · Springer eBooks · doi:10.1007/978-1-4757-1137-0_4 · Cited by 6
New Clinical Concepts on Neuroleptic-Induced Supersensitivity Disorders: Tardive Dyskinesia and Supersensitivity Psychosis
Chouinard, G., & Steinberg, S. I. (1984) · Springer eBooks · doi:10.1007/978-94-011-7618-7_13 · Cited by 6
Reversibility of Tardive Dyskinesia
Itoh, H., & Yagi, G. (1979) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.1979.tb00173.x · Cited by 6
Tardive dyskinesia after low-dose haloperidol
Peabody, C. A., Brody, D. S., & Warner, M. D. (1987) · Biological Psychiatry · doi:10.1016/0006-3223(87)90138-7 · Cited by 5
Relationship of Mitten Patterns to Neuroleptic Drug Induced Dyskinesias in Psychiatric Patients: Early Investigative Findings
Struve, F. A., Kane, J. M., Wegner, J. T., & Kantor, J. S. (1979) · Clinical Electroencephalography · doi:10.1177/155005947901000304 · Cited by 5
The life expectancy of schizophrenic patients with tardive dyskinesia
Inada, T., Koshiishi, M., Ohnishi, K., & Yagi, G. (1992) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.470070404 · Cited by 5
Movement Disorders and Neuroleptic Medication
Barnes, T. R. E., & Weller, M. P. I. (1986) · Springer eBooks · doi:10.1007/978-1-4684-5038-5_18 · Cited by 5
Effect of Long-Term Neuroleptic Treatment on Neurotransmitter Receptors: Relation to Tardive Dyskinesia
Muller, P., & Seeman, P. (1980) · Springer eBooks · doi:10.1007/978-94-011-6381-1_10 · Cited by 5
Antiparkinsonian Medication Withdrawal in the Treatment of Tardive Dyskinesia: A Report of Three Cases
YASSA, R. (1985) · The Canadian Journal of Psychiatry · doi:10.1177/070674378503000614 · Cited by 4
“This was also noted by Quitkin et al (16) who observed that first symptoms of TD rarely persisted if antipsychotics were discontinued and concluded that the length of time symptoms have persisted prior to drug discontinuation may be the major variable determining reversibility of the syndrome.”
A Drug-free Month for Outpatient Schizophrenics
Carpenter, W. T. (1978) · Schizophrenia Bulletin · doi:10.1093/schbul/4.2.148 · Cited by 4
“…detected early, may be a re- by guest on N ovem ber 8, 2016 http://schizophreniabulletin.oxfordjournals.org/ D ow nloaded from VOL. 4, NO. 2, 1978 149 versible neurologic syndrome if medication is not continued (Crane 1975, Jacobson and Baldessarini 1975, Jus et al. 1976,.and Quitkin et al. 1977).”
Background
A Summary of Current Information, Mechanisms and Treatment
Inoue, F. (1979) · Annals of Pharmacotherapy · doi:10.1177/106002807901300402 · Cited by 4
A Classification of the Neurologic Effects of Neuroleptic Drugs
Crane, G. E. (1980) · Springer eBooks · doi:10.1007/978-94-011-6381-1_18 · Cited by 4
Tardive neuroleptic-induced dyskinesias
Захаров, Д. В., Buriak, I. V., & Mihailov, V. A. (2022) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro202212201131 · Cited by 3
Rabbit syndrome: patchy disapperance in stage 1 nrem sleep.
Gangadhar, B. N., John, C., Chattergi, S., Keshavan, M. S., & Narayanan, H. S. (1981) · PubMed Central · Cited by 3
Neuropsychological and Electroencephalographic Correlates of Neuroleptic Induced Involuntary Movements: Implications for Tardive Dyskinesia
Struve, F. A., Ramsey, P. P., Kane, J. M., & Willner, A. E. (1982) · Springer eBooks · doi:10.1007/978-94-009-7654-2_56 · Cited by 3
The Tardive Syndromes
Fahn, S., Jankovic, J. J., Hallett, M., & Jenner, P. G. (2007) · Elsevier eBooks · doi:10.1016/b978-0-443-07941-2.50023-1 · Cited by 2
Tardive Dyskinesia and Institutional Practice: Current Issues and Guidelines
Opler, L. A., Katz, I. R., Kobayashi, J. S., & Ruiz, P. (1980) · Psychiatric Services · doi:10.1176/ps.31.4.239 · Cited by 2
Tardive Dyskinesia: A Review of the Treatment Possibilities
Jeste, D. V., & Wyatt, R. J. (1980) · Psychiatric Annals · doi:10.3928/0048-5713-19800101-05 · Cited by 2
Tardive dyskinesia following low doses of piperacetazine
Dominguez, R. A. (1980) · American Journal of Psychiatry · doi:10.1176/ajp.137.12.1617 · Cited by 2
Deanol Trials in Tardive Dyskinesia
Casey, D. E. (1979) · Springer eBooks · doi:10.1007/978-1-4613-2934-3_10 · Cited by 2
Dyskinesia in chronic schizophrenia: an examination of the psychiatric nurse's perspective and its implications for physiotherapy
Lynn, S. A., & Plant, R. (1995) · Clinical Rehabilitation · doi:10.1177/026921559500900202 · Cited by 1

Authors: Quitkin, F. M., Rifkin, A. E., Gochfeld, L., & Klein, D. F.
Venue: American Journal of Psychiatry
Publisher: American Psychiatric Association Publishing
Published: 1977-01-01
Volume: 134
Issue: 1
Pages: 84-87
ISSN: 0002-953X (ISSN-L)
1535-7228
DOI: 10.1176/ajp.134.1.84
OpenAlex: W2414414545
Cited by: 114
References: 16
Citations by year: 2022: 2 · 2021: 1 · 2020: 3 · 2019: 2 · 2018: 3 · 2017: 1 · 2014: 1
FWCI: 16.68
Type: journal article
Language: en
Open access: closed
Locations: American Journal of Psychiatry (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
Health Sciences › Medicine › Psychiatry and Mental health › Electroconvulsive Therapy Studies
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
Keywords: tardive dyskinesia, antipsychotic adverse effects, reversibility, antipsychotic discontinuation, symptom duration, age of onset, psychiatric patients
MeSH terms: Adult, Chlorpromazine, Dyskinesia, Drug-Induced, Female, Fluphenazine, Haloperidol, Humans, Male, Middle Aged, Prognosis, Remission, Spontaneous, Antipsychotic Agents

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Tardive dyskinesia: are first signs reversible?

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks